Blood outgrowth endothelial cells overexpressing eNOS mitigate pulmonary hypertension in rats: a unique carrier cell enabling autologous cell-based gene therapy

Arif Somani, Sethu L. Nair, Liming Milbauer, Guangshuo Zhu, Suchitra Sajja, Anna Solovey, Yingjie Chen, Robert P Hebbel

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


We have investigated a unique cell type, blood outgrowth endothelial cells (BOEC), as a cell-based gene therapy approach to pulmonary hypertension. BOEC are bona fide endothelial cells, obtained from peripheral blood, that can be expanded to vast numbers, and are amenable to both cryopreservation and genetic modification. We established primary cultures of rat BOEC and genetically altered them to over-express human eNOS plus green fluorescent protein (rBOEC/eNOS) or to express GFP only (rBOEC/GFP). We gave monocrotaline to rats on day 0, and they developed severe pulmonary hypertension. As a Prevention model, we infused saline or rBOEC/GFP or rBOEC/eNOS on day 3, and then examined endpoints on day 24. The rBOEC/eNOS recipients developed elevated NOx (serum and lung) and less severe: elevation of right ventricular systolic pressure (RVSP), right ventricular hypertrophy, and pulmonary arteriolar muscularization and loss of alveolar density. As an Intervention model, we waited until day 21 to give the test infusions, and we examined endpoints on day 35. The rBOEC/eNOS recipients again developed elevated NOx and manifested the same improvements. Indeed, rBOEC/eNOS infusion not only prevented worsening of RVSP but also partially reversed established arteriolar muscularization. These data suggest that BOEC may be useful as a carrier cell for genetic strategies targeting pulmonary hypertension. Their properties render BOEC amenable to preclinical and scale-up studies, available for autologous therapies, and tolerant of modification and storage for potential future use in patients at risk for PAH, eg, as defined by genetics or medical condition.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalTranslational Research
StatePublished - Aug 2019

Bibliographical note

Funding Information:
The authors thank Fuad Abdulla, Rahn Kollander, and James Kiley for assistance with this project. Further, A. Somani acknowledges his early mentorship afforded by Dr David N. Cornfield during study development, supported by University Pediatric Foundation Grant, Irvine McQuarrie Research Scholar Award, and Minnesota Medical Foundation Grant to A. Somani; and NIH P01 HL5552 to R. P. Hebbel. All authors have read the journal's authorship agreement and this manuscript has been reviewed by and approved by all named authors.

Publisher Copyright:
© 2019 Elsevier Inc.

Copyright 2019 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Blood outgrowth endothelial cells overexpressing eNOS mitigate pulmonary hypertension in rats: a unique carrier cell enabling autologous cell-based gene therapy'. Together they form a unique fingerprint.

Cite this